ProQR Therapeutics N.V. Stock News

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tra

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of t

Analysts have provided the following ratings for ProQR Therapeutics (NASDAQ:PRQR) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 2 0 0

Penny stocks under $1 to watch right now. The post Best Penny Stocks To Buy Now? 7 Stocks Under $1 With Big News Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 13, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of t

ProQR Therapeutics N.V. (NASDAQ: PRQR) has decided to prioritize the development of genetic eye disease candidates and the Axiomer RNA base-editing technology platform.

Penny stocks under $1 to watch right now. The post Best Penny Stocks To Buy Now?

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tra

LEIDEN, Netherlands & CAMBRIDGE, Mass., March 23, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of t

ProQR Therapeutics N.V. (NASDAQ:PRQR) with the stream of 3.15% also noticed, India Enservco Corporation (AMEX:ENSV) encountered a rapid change of 85.19% in the last hour of Monday’s trading session. ProQR … The post Glistering Stock: ProQR Therapeutics N.V. (NASDAQ:PRQR), Enservco Corporation (AMEX:ENSV) appeared first on Stocks Equity .

LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of t

ProQR (PRQR) delivered earnings and revenue surprises of -15.38% and 69.50%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

During the last session, ProQR Therapeutics N.V. (NASDAQ:PRQR)’s traded shares were 3.38 million, with the beta value of the company hitting 0.57. At the end of the trading day, the stock’s price was $1.20, reflecting an intraday loss of -1.64% or -$0.02. The 52-week high for the PRQR share is $9.46, that puts it down … Is ProQR Therapeutics N.V. (NASDAQ: PRQR) Still A Loss Stock Despite Being Down -85.02% YTD? Read More »

ProQR (PRQR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

In the last trading session, 8.62 million shares of the ProQR Therapeutics N.V. (NASDAQ:PRQR) were traded, and its beta was 0.57. Most recently the company’s share price was $1.25, and it changed around -$0.14 or -10.07% from the last close, which brings the market valuation of the company to $360.89M. PRQR currently trades at a … Why ProQR Therapeutics N.V. (NASDAQ: PRQR) Stock Should Not Be Discarded By Investors In 2022 Read More »